The updated vancomycin guideline for treatment of serious methicillin-resistant infections prompted institutions to convert from trough to area-under-the-curve monitoring. The physician perception of the transition, coupled with that of pharmacists, was measured by pre- and postimplementation surveys. Both groups believed safety would be increased without efficacy changes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726509 | PMC |
| http://dx.doi.org/10.1017/ash.2022.282 | DOI Listing |
Publication Analysis
Top Keywords
pharmacist physician
4
physician insight
4
insight vancomycin
4
vancomycin therapeutic
4
therapeutic drug-monitoring
4
drug-monitoring changes
4
changes updated
4
updated vancomycin
4
vancomycin guideline
4
guideline treatment
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!